ARArcturus Therapeutics Holdings Inc. ARCT · NASDAQ
$10.87 +13.94% (+$1.33)
- Market cap
- $309.0M
- Enterprise value
- $140.4M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 13.0x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -53.0%
- Gross margin
- 83.2%
- Net margin
- -391.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.48
- Free float
- 92.0%
About the company
Arcturus Therapeutics Holdings Inc. (ARCT) is an American biotechnology company specializing in the development and research of messenger RNA (mRNA)-based therapeutics. With innovative approaches to treating diseases, including infectious diseases and genetic disorders, Arcturus Therapeutics Holdings Inc. is a key player in the field of biotechnology. The company focuses on harnessing mRNA for the development of novel therapeutic solutions. Arcturus Therapeutics Holdings Inc. (ARCT) shares could be suitable for investors looking to invest in the biotechnology sector with innovative and promising therapeutic approaches.
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph E. Payne
Employees
109
Headquarters
San Diego
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 31% a year over the last 3 years.
- What to watch: Analysts expect revenue to fall by 73% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $191.5M against $22.9M.
- What to watch: It passes only 1 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number